84 related articles for article (PubMed ID: 23667173)
1. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.
Penna E; Orso F; Cimino D; Vercellino I; Grassi E; Quaglino E; Turco E; Taverna D
Cancer Res; 2013 Jul; 73(13):4098-111. PubMed ID: 23667173
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of miR-214 expression by small molecules alleviates head and neck cancer metastasis by targeting ALCAM/TFAP2 signaling.
Agarwal A; Kansal V; Farooqi H; Prasad R; Singh VK
bioRxiv; 2023 Apr; ():. PubMed ID: 37066273
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic, Prognostic, and Therapeutic Value of miR-148b in Human Cancers.
Bahrami A; Ferns GA
Curr Mol Med; 2022; 22(10):860-869. PubMed ID: 34961461
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views.
Jin C; Luo Y; Liang Z; Li X; Kołat D; Zhao L; Xiong W
J Transl Med; 2023 Jun; 21(1):371. PubMed ID: 37291585
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma.
Staebler S; Rottensteiner-Brandl U; El Ahmad Z; Kappelmann-Fenzl M; Arkudas A; Kengelbach-Weigand A; Bosserhoff AK; Schmidt SK
Cell Death Dis; 2024 May; 15(5):351. PubMed ID: 38773108
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for specific DNA sequence motif recognition by the TFAP2 transcription factors.
Liu K; Xiao Y; Gan L; Li W; Zhang J; Min J
Nucleic Acids Res; 2023 Aug; 51(15):8270-8282. PubMed ID: 37409559
[TBL] [Abstract][Full Text] [Related]
7. TFAP2 paralogs regulate midfacial development in part through a conserved
Nguyen TT; Mitchell JM; Kiel MD; Jones KL; Williams TJ; Nichols JT; Van Otterloo E
bioRxiv; 2023 Jun; ():. PubMed ID: 37398373
[TBL] [Abstract][Full Text] [Related]
8. miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.
Orso F; Quirico L; Virga F; Penna E; Dettori D; Cimino D; Coppo R; Grassi E; Elia AR; Brusa D; Deaglio S; Brizzi MF; Stadler MB; Provero P; Caselle M; Taverna D
Cancer Res; 2016 Sep; 76(17):5151-62. PubMed ID: 27328731
[TBL] [Abstract][Full Text] [Related]
9. miR-214 as a key hub that controls cancer networks: small player, multiple functions.
Penna E; Orso F; Taverna D
J Invest Dermatol; 2015 Apr; 135(4):960-969. PubMed ID: 25501033
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.
Dettori D; Orso F; Penna E; Baruffaldi D; Brundu S; Maione F; Turco E; Giraudo E; Taverna D
Mol Ther; 2018 Aug; 26(8):2008-2018. PubMed ID: 29929788
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑214 promotes the EMT process in melanoma by downregulating CADM1 expression.
Wang SJ; Li WW; Wen CJ; Diao YL; Zhao TL
Mol Med Rep; 2020 Nov; 22(5):3795-3803. PubMed ID: 33000202
[TBL] [Abstract][Full Text] [Related]
12. Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma.
Prabhakar K; Rodrίguez CI; Jayanthy AS; Mikheil DM; Bhasker AI; Perera RJ; Setaluri V
Mol Carcinog; 2019 Nov; 58(11):1974-1984. PubMed ID: 31338875
[TBL] [Abstract][Full Text] [Related]
13. Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression.
Quirico L; Orso F; Esposito CL; Bertone S; Coppo R; Conti L; Catuogno S; Cavallo F; de Franciscis V; Taverna D
Int J Biol Sci; 2020; 16(7):1238-1251. PubMed ID: 32174798
[TBL] [Abstract][Full Text] [Related]
14. Stroma-derived miR-214 coordinates tumor dissemination.
Orso F; Virga F; Dettori D; Dalmasso A; Paradzik M; Savino A; Pomatto MAC; Quirico L; Cucinelli S; Coco M; Mareschi K; Fagioli F; Salmena L; Camussi G; Provero P; Poli V; Mazzone M; Pandolfi PP; Taverna D
J Exp Clin Cancer Res; 2023 Jan; 42(1):20. PubMed ID: 36639824
[TBL] [Abstract][Full Text] [Related]
15. miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial Migration.
Andreucci E; Ruzzolini J; Bianchini F; Versienti G; Biagioni A; Lulli M; Guasti D; Nardini P; Serratì S; Margheri F; Laurenzana A; Nediani C; Peppicelli S; Calorini L
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291876
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Therapeutic miR-148b Mimic via Poly(β Amino Ester) Polyplexes for Post-transcriptional Gene Regulation and Apoptosis of A549 Cells.
Alden NA; Arrizabalaga JH; Liu Y; Amin S; Gowda K; Yao S; Archetti M; Glick AB; Hayes DJ
Langmuir; 2022 Aug; 38(32):9833-9843. PubMed ID: 35916504
[TBL] [Abstract][Full Text] [Related]
17. The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.
Shi T; Zhang C; Xia S
Mol Cell Biochem; 2022 May; 477(5):1371-1380. PubMed ID: 35142950
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-214 in Health and Disease.
Amin MMJ; Trevelyan CJ; Turner NA
Cells; 2021 Nov; 10(12):. PubMed ID: 34943783
[TBL] [Abstract][Full Text] [Related]
19. The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers.
Yang Y; Sanders AJ; Dou QP; Jiang DG; Li AX; Jiang WG
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680335
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic clock and methylation studies in vervet monkeys.
Jasinska AJ; Haghani A; Zoller JA; Li CZ; Arneson A; Ernst J; Kavanagh K; Jorgensen MJ; Mattison JA; Wojta K; Choi OW; DeYoung J; Li X; Rao AW; Coppola G; Freimer NB; Woods RP; Horvath S
Geroscience; 2022 Apr; 44(2):699-717. PubMed ID: 34591235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
